GLYCOGEN
GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 19 | 3.0 | 2.4 | 0.6 | 0.1 | -1.605 | 0.2442 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
2 | 31 | 10.8 | 10.4 | 0.3 | 0.1 | -2.214 | 0.1122 | ACACA | acetyl-CoA carboxylase alpha |
3 | 43 | 6.1 | 6.4 | 0.4 | 0.3 | 1.045 | 0.3591 | ACHE | acetylcholinesterase (Yt blood group) |
4 | 8309 | 5.1 | 5.6 | 0.3 | 0.3 | 2.462 | 0.0695 | ACOX2 | acyl-CoA oxidase 2, branched chain |
5 | 174 | 2.4 | 2.4 | 0.0 | 0.0 | -0.287 | 0.7900 | AFP | alpha-fetoprotein |
6 | 178 | 9.1 | 9.2 | 0.4 | 0.1 | 0.458 | 0.6825 | AGL | amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
7 | 231 | 2.7 | 5.8 | 0.3 | 0.1 | 16.078 | 0.0023 | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
8 | 208 | 9.1 | 9.3 | 0.2 | 0.1 | 1.847 | 0.1386 | AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
9 | 213 | 3.2 | 2.8 | 0.4 | 0.5 | -1.148 | 0.3190 | ALB | albumin |
10 | 353 | 16.3 | 16.0 | 0.1 | 0.1 | -5.812 | 0.0044 | APRT | adenine phosphoribosyltransferase |
11 | 481 | 10.2 | 13.5 | 0.2 | 0.1 | 24.123 | 0.0000 | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide |
12 | 51761 | 2.8 | 4.2 | 0.2 | 0.2 | 8.068 | 0.0017 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
13 | 9212 | 8.7 | 10.0 | 0.2 | 0.2 | 7.824 | 0.0014 | AURKB | aurora kinase B |
14 | 27241 | 6.8 | 6.8 | 0.6 | 0.7 | 0.060 | 0.9553 | BBS9 | Bardet-Biedl syndrome 9 |
15 | 78996 | 9.9 | 11.0 | 0.2 | 0.1 | 9.881 | 0.0048 | C7orf49 | chromosome 7 open reading frame 49 |
16 | 836 | 8.2 | 8.0 | 0.3 | 0.2 | -1.211 | 0.3082 | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
17 | 867 | 8.4 | 8.5 | 0.4 | 0.5 | 0.376 | 0.7268 | CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase |
18 | 947 | 2.6 | 2.4 | 0.1 | 0.1 | -2.834 | 0.0480 | CD34 | CD34 molecule |
19 | 960 | 13.9 | 11.7 | 0.4 | 0.2 | -8.327 | 0.0057 | CD44 | CD44 molecule (Indian blood group) |
20 | 1000 | 3.2 | 3.2 | 0.4 | 0.1 | 0.188 | 0.8677 | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) |
21 | 629 | 6.0 | 6.3 | 2.5 | 0.9 | 0.191 | 0.8633 | CFB | complement factor B |
22 | 341947 | 2.8 | 3.0 | 0.2 | 0.3 | 1.353 | 0.2543 | COX8C | cytochrome c oxidase subunit VIIIC |
23 | 1447 | 2.3 | 2.5 | 0.0 | 0.3 | 0.975 | 0.4313 | CSN2 | casein beta |
24 | 54205 | 10.8 | 10.8 | 0.4 | 0.3 | 0.041 | 0.9690 | CYCS | cytochrome c, somatic |
25 | 114757 | 13.4 | 13.0 | 0.1 | 0.2 | -2.755 | 0.0760 | CYGB | cytoglobin |
26 | 1558 | 2.2 | 2.8 | 0.0 | 0.6 | 1.477 | 0.2775 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 |
27 | 1581 | 2.5 | 2.6 | 0.5 | 0.6 | 0.134 | 0.9002 | CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 |
28 | 4921 | 2.6 | 2.9 | 0.4 | 0.4 | 0.964 | 0.3899 | DDR2 | discoidin domain receptor tyrosine kinase 2 |
29 | 1666 | 11.2 | 10.5 | 0.2 | 0.3 | -3.384 | 0.0309 | DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial |
30 | 1674 | 8.3 | 7.9 | 0.3 | 0.1 | -2.309 | 0.1312 | DES | desmin |
31 | 79947 | 5.9 | 6.2 | 0.3 | 0.1 | 1.482 | 0.2367 | DHDDS | dehydrodolichyl diphosphate synthase |
32 | 1719 | 9.6 | 10.1 | 0.4 | 0.2 | 1.772 | 0.1628 | DHFR | dihydrofolate reductase |
33 | 51705 | 7.4 | 7.9 | 0.2 | 0.2 | 2.761 | 0.0595 | EMCN | endomucin |
34 | 2022 | 3.2 | 2.8 | 0.0 | 0.1 | -7.710 | 0.0123 | ENG | endoglin |
35 | 2023 | 14.2 | 14.3 | 0.1 | 0.2 | 0.573 | 0.6005 | ENO1 | enolase 1, (alpha) |
36 | 2048 | 5.7 | 5.8 | 0.3 | 0.2 | 0.700 | 0.5288 | EPHB2 | EPH receptor B2 |
37 | 7957 | 3.6 | 3.9 | 0.1 | 0.5 | 1.226 | 0.3367 | EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
38 | 2109 | 14.1 | 14.3 | 0.2 | 0.2 | 1.350 | 0.2482 | ETFB | electron-transfer-flavoprotein, beta polypeptide |
39 | 2155 | 5.3 | 5.6 | 1.1 | 0.3 | 0.465 | 0.6832 | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
40 | 144717 | 7.2 | 7.6 | 0.2 | 0.2 | 2.499 | 0.0694 | FAM109A | family with sequence similarity 109, member A |
41 | 9965 | 2.7 | 2.7 | 0.2 | 0.3 | 0.264 | 0.8090 | FGF19 | fibroblast growth factor 19 |
42 | 2321 | 2.4 | 2.5 | 0.1 | 0.1 | 0.409 | 0.7102 | FLT1 | fms-related tyrosine kinase 1 |
43 | 3170 | 2.4 | 2.4 | 0.0 | 0.0 | 0.205 | 0.8541 | FOXA2 | forkhead box A2 |
44 | 2308 | 8.2 | 7.3 | 0.4 | 0.3 | -3.392 | 0.0322 | FOXO1 | forkhead box O1 |
45 | 2538 | 2.6 | 2.3 | 0.9 | 0.3 | -0.595 | 0.6009 | G6PC | glucose-6-phosphatase, catalytic subunit |
46 | 2548 | 15.0 | 14.7 | 0.1 | 0.2 | -2.315 | 0.1147 | GAA | glucosidase, alpha; acid |
47 | 11345 | 11.5 | 10.9 | 0.2 | 0.2 | -3.665 | 0.0267 | GABARAPL2 | GABA(A) receptor-associated protein-like 2 |
48 | 2632 | 10.1 | 9.2 | 0.1 | 0.1 | -11.910 | 0.0009 | GBE1 | glucan (1,4-alpha-), branching enzyme 1 |
49 | 2641 | 3.4 | 3.2 | 0.3 | 0.1 | -0.748 | 0.5163 | GCG | glucagon |
50 | 2645 | 4.8 | 4.7 | 0.1 | 0.2 | -0.602 | 0.5904 | GCK | glucokinase (hexokinase 4) |
51 | 2670 | 2.6 | 2.5 | 0.3 | 0.1 | -0.353 | 0.7465 | GFAP | glial fibrillary acidic protein |
52 | 8836 | 11.7 | 11.7 | 0.2 | 0.3 | 0.138 | 0.8981 | GGH | gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
53 | 9837 | 11.7 | 12.2 | 0.2 | 0.4 | 2.240 | 0.1160 | GINS1 | GINS complex subunit 1 (Psf1 homolog) |
54 | 2746 | 12.8 | 12.4 | 0.2 | 0.3 | -2.053 | 0.1189 | GLUD1 | glutamate dehydrogenase 1 |
55 | 51206 | 2.6 | 2.5 | 0.2 | 0.3 | -0.134 | 0.9012 | GP6 | glycoprotein VI (platelet) |
56 | 11318 | 3.8 | 3.4 | 0.7 | 1.1 | -0.512 | 0.6414 | GPR182 | G protein-coupled receptor 182 |
57 | 2876 | 3.7 | 3.9 | 0.4 | 0.6 | 0.580 | 0.5999 | GPX1 | glutathione peroxidase 1 |
58 | 2932 | 11.4 | 11.2 | 0.1 | 0.1 | -2.447 | 0.0981 | GSK3B | glycogen synthase kinase 3 beta |
59 | 2992 | 10.8 | 10.6 | 0.1 | 0.1 | -4.673 | 0.0127 | GYG1 | glycogenin 1 |
60 | 2997 | 11.0 | 10.7 | 0.0 | 0.1 | -3.807 | 0.0355 | GYS1 | glycogen synthase 1 (muscle) |
61 | 2998 | 2.7 | 2.8 | 0.2 | 0.3 | 0.366 | 0.7359 | GYS2 | glycogen synthase 2 (liver) |
62 | 3043 | 2.4 | 2.4 | 0.0 | 0.0 | 0.209 | 0.8450 | HBB | hemoglobin, beta |
63 | 8924 | 6.8 | 7.1 | 0.1 | 0.2 | 2.618 | 0.1049 | HERC2 | HECT and RLD domain containing E3 ubiquitin protein ligase 2 |
64 | 3091 | 9.2 | 9.4 | 0.1 | 0.0 | 3.235 | 0.0743 | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
65 | 3098 | 12.0 | 11.8 | 0.2 | 0.1 | -1.634 | 0.1893 | HK1 | hexokinase 1 |
66 | 6928 | 3.1 | 2.5 | 0.1 | 0.3 | -3.881 | 0.0447 | HNF1B | HNF1 homeobox B |
67 | 3172 | 2.5 | 2.6 | 0.1 | 0.3 | 0.917 | 0.4463 | HNF4A | hepatocyte nuclear factor 4, alpha |
68 | 3290 | 2.7 | 2.3 | 0.7 | 0.0 | -0.995 | 0.4239 | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
69 | 3360 | 2.4 | 2.3 | 0.2 | 0.1 | -0.720 | 0.5356 | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
70 | 3416 | 10.6 | 11.0 | 0.1 | 0.3 | 2.154 | 0.1364 | IDE | insulin-degrading enzyme |
71 | 3458 | 2.4 | 2.3 | 0.1 | 0.0 | -1.013 | 0.3856 | IFNG | interferon, gamma |
72 | 3479 | 2.8 | 2.8 | 0.2 | 0.2 | 0.560 | 0.6057 | IGF1 | insulin-like growth factor 1 (somatomedin C) |
73 | 3482 | 9.2 | 9.2 | 0.2 | 0.1 | -0.039 | 0.9710 | IGF2R | insulin-like growth factor 2 receptor |
74 | 3484 | 2.4 | 2.2 | 0.2 | 0.0 | -0.937 | 0.4466 | IGFBP1 | insulin-like growth factor binding protein 1 |
75 | 3586 | 2.3 | 2.3 | 0.0 | 0.0 | 0.041 | 0.9698 | IL10 | interleukin 10 |
76 | 3569 | 2.3 | 2.3 | 0.0 | 0.0 | -0.440 | 0.6964 | IL6 | interleukin 6 |
77 | 3630 | 3.6 | 4.1 | 0.4 | 0.4 | 1.716 | 0.1617 | INS | insulin |
78 | 3643 | 8.3 | 9.3 | 0.1 | 0.2 | 8.564 | 0.0056 | INSR | insulin receptor |
79 | 3664 | 7.2 | 6.3 | 0.5 | 0.2 | -2.556 | 0.0934 | IRF6 | interferon regulatory factor 6 |
80 | 3667 | 8.5 | 10.0 | 0.3 | 0.2 | 7.365 | 0.0043 | IRS1 | insulin receptor substrate 1 |
81 | 8660 | 8.8 | 10.0 | 0.1 | 0.7 | 2.938 | 0.0938 | IRS2 | insulin receptor substrate 2 |
82 | 8471 | 2.5 | 2.5 | 0.1 | 0.1 | 0.106 | 0.9212 | IRS4 | insulin receptor substrate 4 |
83 | 51477 | 10.7 | 10.2 | 0.2 | 0.1 | -4.309 | 0.0207 | ISYNA1 | inositol-3-phosphate synthase 1 |
84 | 3688 | 9.4 | 9.7 | 0.3 | 0.1 | 1.419 | 0.2744 | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
85 | 3728 | 14.2 | 13.5 | 0.2 | 0.2 | -4.400 | 0.0119 | JUP | junction plakoglobin |
86 | 8570 | 10.7 | 10.9 | 0.3 | 0.2 | 0.790 | 0.4823 | KHSRP | KH-type splicing regulatory protein |
87 | 3875 | 16.9 | 17.7 | 0.0 | 0.0 | 27.338 | 0.0010 | KRT18 | keratin 18, type I |
88 | 3880 | 18.2 | 18.4 | 0.1 | 0.0 | 3.350 | 0.0508 | KRT19 | keratin 19, type I |
89 | 3855 | 11.5 | 12.1 | 0.2 | 0.4 | 1.961 | 0.1604 | KRT7 | keratin 7, type II |
90 | 3856 | 12.3 | 13.0 | 0.1 | 0.1 | 10.763 | 0.0005 | KRT8 | keratin 8, type II |
91 | 3930 | 12.1 | 12.0 | 0.0 | 0.3 | -0.240 | 0.8324 | LBR | lamin B receptor |
92 | 3933 | 2.5 | 2.8 | 0.3 | 0.3 | 0.932 | 0.4043 | LCN1 | lipocalin 1 |
93 | 3939 | 13.5 | 13.5 | 0.2 | 0.3 | 0.040 | 0.9697 | LDHA | lactate dehydrogenase A |
94 | 3952 | 2.6 | 2.6 | 0.2 | 0.2 | 0.503 | 0.6416 | LEP | leptin |
95 | 4012 | 9.0 | 9.3 | 0.2 | 0.1 | 1.967 | 0.1539 | LNPEP | leucyl/cystinyl aminopeptidase |
96 | 4023 | 2.4 | 2.5 | 0.0 | 0.1 | 0.418 | 0.7059 | LPL | lipoprotein lipase |
97 | 5595 | 8.9 | 9.2 | 0.3 | 0.1 | 1.920 | 0.1525 | MAPK3 | mitogen-activated protein kinase 3 |
98 | 10873 | 3.7 | 4.8 | 0.4 | 0.2 | 4.505 | 0.0154 | ME3 | malic enzyme 3, NADP(+)-dependent, mitochondrial |
99 | 4205 | 10.8 | 10.3 | 0.2 | 0.2 | -2.912 | 0.0436 | MEF2A | myocyte enhancer factor 2A |
100 | 4353 | 2.7 | 2.3 | 0.3 | 0.0 | -2.005 | 0.1812 | MPO | myeloperoxidase |
101 | 2660 | 2.4 | 2.4 | 0.1 | 0.0 | -0.695 | 0.5344 | MSTN | myostatin |
102 | 92170 | 8.0 | 8.2 | 0.2 | 0.2 | 1.022 | 0.3647 | MTG1 | mitochondrial ribosome-associated GTPase 1 |
103 | 2475 | 8.9 | 9.1 | 0.0 | 0.1 | 3.319 | 0.0559 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
104 | 4609 | 8.9 | 8.0 | 0.4 | 0.6 | -2.174 | 0.1053 | MYC | v-myc avian myelocytomatosis viral oncogene homolog |
105 | 4698 | 11.7 | 12.2 | 0.2 | 0.1 | 3.835 | 0.0232 | NDUFA5 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 |
106 | 51701 | 10.3 | 9.9 | 0.1 | 0.2 | -2.795 | 0.0788 | NLK | nemo-like kinase |
107 | 2908 | 9.6 | 12.1 | 0.2 | 0.2 | 12.739 | 0.0002 | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
108 | 4925 | 11.7 | 11.7 | 0.1 | 0.0 | -0.849 | 0.4788 | NUCB2 | nucleobindin 2 |
109 | 10133 | 7.3 | 7.4 | 0.2 | 0.1 | 1.199 | 0.3034 | OPTN | optineurin |
110 | 5091 | 10.9 | 10.2 | 0.3 | 0.2 | -3.641 | 0.0231 | PC | pyruvate carboxylase |
111 | 5105 | 2.9 | 3.0 | 0.2 | 0.4 | 0.283 | 0.7964 | PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) |
112 | 5111 | 12.0 | 13.1 | 0.2 | 0.4 | 4.276 | 0.0250 | PCNA | proliferating cell nuclear antigen |
113 | 5166 | 2.3 | 2.5 | 0.0 | 0.2 | 1.329 | 0.3086 | PDK4 | pyruvate dehydrogenase kinase, isozyme 4 |
114 | 5213 | 13.3 | 12.8 | 0.0 | 0.1 | -6.553 | 0.0185 | PFKM | phosphofructokinase, muscle |
115 | 283871 | 9.2 | 9.5 | 0.2 | 0.4 | 1.469 | 0.2460 | PGP | phosphoglycolate phosphatase |
116 | 5245 | 12.7 | 12.9 | 0.2 | 0.3 | 0.724 | 0.5110 | PHB | prohibitin |
117 | 55558 | 11.7 | 11.8 | 0.2 | 0.2 | 0.458 | 0.6717 | PLXNA3 | plexin A3 |
118 | 80339 | 7.4 | 7.5 | 0.1 | 0.2 | 0.580 | 0.6004 | PNPLA3 | patatin-like phospholipase domain containing 3 |
119 | 5443 | 3.0 | 3.3 | 0.4 | 0.6 | 0.757 | 0.5017 | POMC | proopiomelanocortin |
120 | 5468 | 2.3 | 4.0 | 0.0 | 0.5 | 5.713 | 0.0291 | PPARG | peroxisome proliferator-activated receptor gamma |
121 | 10891 | 2.5 | 3.3 | 0.3 | 0.9 | 1.513 | 0.2415 | PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
122 | 5507 | 10.5 | 9.4 | 0.4 | 0.5 | -3.256 | 0.0326 | PPP1R3C | protein phosphatase 1, regulatory subunit 3C |
123 | 7001 | 12.0 | 12.1 | 0.1 | 0.0 | 3.370 | 0.0339 | PRDX2 | peroxiredoxin 2 |
124 | 51422 | 8.5 | 9.8 | 0.3 | 0.1 | 8.367 | 0.0106 | PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
125 | 53632 | 9.8 | 9.8 | 0.3 | 0.3 | -0.145 | 0.8917 | PRKAG3 | protein kinase, AMP-activated, gamma 3 non-catalytic subunit |
126 | 5617 | 2.3 | 2.2 | 0.0 | 0.0 | -0.781 | 0.4880 | PRL | prolactin |
127 | 112476 | 10.8 | 10.5 | 0.2 | 0.2 | -1.846 | 0.1438 | PRRT2 | proline-rich transmembrane protein 2 |
128 | 2185 | 9.1 | 8.2 | 0.0 | 0.4 | -4.284 | 0.0472 | PTK2B | protein tyrosine kinase 2 beta |
129 | 5770 | 11.4 | 11.4 | 0.1 | 0.1 | -0.820 | 0.4598 | PTPN1 | protein tyrosine phosphatase, non-receptor type 1 |
130 | 5834 | 12.4 | 12.3 | 0.2 | 0.1 | -1.150 | 0.3376 | PYGB | phosphorylase, glycogen; brain |
131 | 5837 | 4.3 | 4.4 | 1.8 | 0.2 | 0.119 | 0.9157 | PYGM | phosphorylase, glycogen, muscle |
132 | 5923 | 3.0 | 2.3 | 1.2 | 0.1 | -0.992 | 0.4255 | RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 |
133 | 5068 | 2.5 | 2.5 | 0.4 | 0.2 | -0.112 | 0.9184 | REG3A | regenerating islet-derived 3 alpha |
134 | 6010 | 2.6 | 3.5 | 0.3 | 0.4 | 3.430 | 0.0353 | RHO | rhodopsin |
135 | 10535 | 13.6 | 13.6 | 0.1 | 0.1 | 0.277 | 0.7967 | RNASEH2A | ribonuclease H2, subunit A |
136 | 6261 | 5.8 | 5.9 | 0.4 | 0.1 | 0.448 | 0.6944 | RYR1 | ryanodine receptor 1 (skeletal) |
137 | 29072 | 8.7 | 8.7 | 0.0 | 0.0 | 0.189 | 0.8593 | SETD2 | SET domain containing 2 |
138 | 26503 | 7.7 | 7.4 | 0.6 | 0.2 | -0.857 | 0.4688 | SLC17A5 | solute carrier family 17 (acidic sugar transporter), member 5 |
139 | 6581 | 2.4 | 2.4 | 0.0 | 0.1 | 0.029 | 0.9782 | SLC22A3 | solute carrier family 22 (organic cation transporter), member 3 |
140 | 788 | 8.3 | 7.5 | 0.1 | 0.4 | -3.731 | 0.0611 | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
141 | 6514 | 2.4 | 2.4 | 0.1 | 0.1 | 0.146 | 0.8912 | SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
142 | 6517 | 5.0 | 3.3 | 0.7 | 0.7 | -3.148 | 0.0346 | SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
143 | 6541 | 11.0 | 11.2 | 0.5 | 0.2 | 0.587 | 0.6036 | SLC7A1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
144 | 54498 | 6.0 | 9.2 | 0.1 | 0.2 | 21.753 | 0.0001 | SMOX | spermine oxidase |
145 | 6647 | 16.0 | 16.0 | 0.1 | 0.1 | -0.780 | 0.4796 | SOD1 | superoxide dismutase 1, soluble |
146 | 6657 | 8.7 | 7.1 | 0.4 | 0.4 | -4.799 | 0.0089 | SOX2 | SRY (sex determining region Y)-box 2 |
147 | 6484 | 7.1 | 6.8 | 0.2 | 0.5 | -0.728 | 0.5282 | ST3GAL4 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
148 | 8987 | 6.3 | 6.7 | 0.3 | 0.7 | 0.864 | 0.4506 | STBD1 | starch binding domain 1 |
149 | 6898 | 4.4 | 4.1 | 0.8 | 1.4 | -0.315 | 0.7721 | TAT | tyrosine aminotransferase |
150 | 9882 | 7.3 | 8.4 | 0.1 | 0.2 | 7.431 | 0.0026 | TBC1D4 | TBC1 domain family, member 4 |
151 | 7070 | 2.5 | 3.1 | 0.6 | 1.0 | 0.893 | 0.4333 | THY1 | Thy-1 cell surface antigen |
152 | 11011 | 10.3 | 10.3 | 0.1 | 0.1 | 0.133 | 0.9020 | TLK2 | tousled-like kinase 2 |
153 | 7097 | 2.9 | 5.0 | 0.8 | 0.9 | 2.980 | 0.0417 | TLR2 | toll-like receptor 2 |
154 | 7124 | 3.9 | 4.1 | 2.4 | 0.7 | 0.111 | 0.9206 | TNF | tumor necrosis factor |
155 | 7157 | 7.9 | 7.4 | 0.3 | 0.5 | -1.440 | 0.2378 | TP53 | tumor protein p53 |
156 | 11181 | 2.8 | 2.8 | 0.2 | 0.4 | 0.182 | 0.8664 | TREH | trehalase (brush-border membrane glycoprotein) |
157 | 3093 | 14.2 | 14.1 | 0.1 | 0.1 | -1.367 | 0.2485 | UBE2K | ubiquitin-conjugating enzyme E2K |
158 | 8266 | 8.8 | 9.1 | 0.1 | 0.0 | 2.899 | 0.0893 | UBL4A | ubiquitin-like 4A |
159 | 7422 | 8.5 | 8.5 | 0.5 | 0.2 | 0.009 | 0.9937 | VEGFA | vascular endothelial growth factor A |
160 | 7431 | 4.9 | 6.7 | 0.5 | 0.1 | 6.548 | 0.0153 | VIM | vimentin |
161 | 23038 | 7.7 | 7.6 | 0.3 | 0.2 | -0.598 | 0.5828 | WDTC1 | WD and tetratricopeptide repeats 1 |
162 | 158506 | 2.8 | 2.3 | 0.5 | 0.0 | -2.007 | 0.1823 | ZNF645 | zinc finger protein 645 |